Product Information

MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $23.0395 per ML under NDC 00548540025. Its NADAC has been published 347 times since Apr 11, 2018.

FDA first approved this application on Nov 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEDROXYPROGESTERONE 150 MG/ML

Medroxyprogesterone acetate
$23.0395per ML

Strength

150 mg/mL

NDC

00548540025

Classification

Generic

Dosage Form

INJECTION, SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Effective Date

10/21/2026

Active Ingredients

MEDROXYPROGESTERONE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077235

FDA Approved

11/28/2017

TE Code

AB

On Market Since

11/28/2017

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 347 times since Apr 11, 2018, and over the history we have for it it has declined 67.6%. The table below summarizes its recorded NADAC range and movement.

Current price$23.0395 per ML
All-time high$71.1988 (Apr 11, 2018)
All-time low$18.4128 (Jul 22, 2026)
52-week high$23.0395
52-week low$18.4128
Median price$30.7723
Average price$33.0726
Largest weekly change+40.2% (Sep 22, 2021)
Weeks tracked347
Tracking sinceApr 11, 2018

Price History

1W

0.0%

1M

+0.8%

3M

+25.1%

6M

+11.1%

1Y

+18.9%

3Y

-25.1%

5Y

-25.1%

All

-67.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 22%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?

The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Amphastar Pharmaceuticals, Inc., is $23.0395 per ML (NDC 00548540025), effective Nov 11, 2026.

How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?

Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has declined 67.6%. It has been tracked across 347 weekly CMS publications since Apr 11, 2018.

What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?

Since Apr 11, 2018, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $18.4128 (Jul 22, 2026) to a high of $71.1988 (Apr 11, 2018), with a median of $30.7723 per ML.

Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $17.8569 per ML — about 22% below MEDROXYPROGESTERONE 150 MG/ML.

Who manufactures MEDROXYPROGESTERONE 150 MG/ML?

MEDROXYPROGESTERONE 150 MG/ML (NDC 00548540025) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.